Abstract
The microenvironment of a tumour differs significantly from that of a normal tissue due to abnormal vasculature and altered cellular metabolism in tumours. Microenvironmental conditions in tumours, which include hypoxia, acidity, nutrient deprivation and high interstitial fluid pressure, have been associated with metastatic tumour progression both experimentally and clinically. The mechanisms by which this occurs are believed to include genomic instability, changes in gene expression levels and microenvironment-mediated selective pressure. These genomic changes modify cell survival and growth during the angiogenic, migratory and invasive stages of tumour progression and metastasis. This chapter summarises the data examining links between tumour microenvironment and metastasis and discusses the possibility of using microenvironmentally regulated genes as intrinsic prognostic markers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown, J. M., 2000, Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today, 7:157–162.
Hockel, M., and Vaupel, P., 2001, Biological consequences of tumor hypoxia. Semin Oncol, 28:36–41.
Hockel, M., and Vaupel, P., 2001, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst, 93:266–276
Dewhirst, M. W., 1998, Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol, 8:143–150.
Becker, A., Hansgen, G., Bloching, M., Weigel, C., Lautenschlager, C., and Dunst, J., 1998, Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys, 42:35–41.
Le, Q. T., Kovacs, M. S., Dorie, M. J., Koong, A., Terris, D. J., Pinto, H. A., Goffinet, D. R., Nowels, K., Bloch, D., and Brown, J. M., 2003, Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys, 56:375–383.
Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., Brown, J. M., Bastidas, A. J., and Vierra, M., 2000, Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys, 48:919–922.
Parker, C., Milosevic, M., Toi, A., Sweet, J., Panzarella, T., Bristow, R., Catton, C., Catton, P., Crook, J., Gospodarowicz, M., et al., 2004, Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys, 58:750–757.
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., and West, C. M., 2001, Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res, 61:6394–6399.
Bentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J., Nielsen, O. S., and Overgaard, J., 2003, Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol, 67:339–344.
Vaupel, P., Mayer, A., Briest, S., and Hockel, M., 2003, Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res, 63:7634–7637.
Tyler, J. L., Diksic, M., Villemure, J. G., Evans, A. C., Meyer, E., Yamamoto, Y. L., and Feindel, W., 1987, Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med, 28:1123–1133.
Shinkwin, M. A., Lenkinski, R. E., Daly, J. M., Zlatkin, M. B., Frank, T. S., Holland, G. A., and Kressel, H. Y., 1991, Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors. Cancer, 67:1849–1858.
van de Merwe, S. A., van den Berg, A. P., Kroon, B. B., van den Berge, A. W., Klaase, J. M., and van der Zee, J., 1993, Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study. Int J Hyperthermia, 9:205–217.
Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., and McFarlane, J. D., 1995, Extracellular pH distribution in human tumours. Int J Hyperthermia, 11:211–216.
Boucher, Y., Kirkwood, J. M., Opacic, D., Desantis, M., and Jain, R. K., 1991, Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res, 51:6691–6694.
Roh, H. D., Boucher, Y., Kalnicki, S., Buchsbaum, R., Bloomer, W. D., and Jain, R. K., 1991, Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res, 51:6695–6698.
Less, J. R., Posner, M. C., Boucher, Y., Borochovitz, D., Wolmark, N., and Jain, R. K., 1992, Interstitial hypertension in human breast and colorectal tumors. Cancer Res, 52:6371–6374.
Gutmann, R., Leunig, M., Feyh, J., Goetz, A. E., Messmer, K., Kastenbauer, E., and Jain, R. K., 1992, Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res, 52:1993–1995.
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P., 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res, 56:4509–4515.
Hall, E. J., 2000, Radiobiology for the Radiologist, 5th edition. Lippincott Williams and Wilkins, Philadelphia PA.
Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W., 1996, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res, 56:941–943.
Rofstad, E. K., 2000, Microenvironment-induced cancer metastasis. Int J Radiat Biol, 76:589–605.
Subarsky, P. and Hill, R. P., 2003, The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis, 20:237–250.
Coomber, B. L., Yu, J. L., Fathers, K. E., Plumb, C., and Rak, J. W., 2003, Angiogenesis and the role of epigenetics in metastasis. Clin Exp Metastasis, 20:215–227.
Zhang, L. and Hill, R. P., 2004, Hypoxia enhances metastatic efficiency by up regulating mdm2 in KHT cells and increasing resistance to apoptosis.
Airley, R., Loncaster, J., Davidson, S., Bromley, M., Roberts, S., Patterson, A., Hunter, R., Stratford, I., and West, C., 2001, Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res, 7:928–934.
Rofstad, E. K. and Halsør, E. F., 2002, Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. Br J Cancer, 86:301–308.
Cairns, R. A., Kalliomaki, T., and Hill, R. P., 2001, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res, 61:8903–8908.
Cairns, R. A., and Hill, R. P., 2004, Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res, 64:2054–2061.
Stubbs, M., McSheehy, P. M., Griffiths, J. R., and Bashford, C. L., 2000, Causes and consequences of tumour acidity and implications for treatment. Mol Med Today, 6:15–19.
Griffiths, J. R., 1991, Are cancer cells acidic? Br J Cancer, 64:425–427.
Walenta, S., Snyder, S., Haroon, Z. A., Braun, R. D., Amin, K., Brizel, D., Mueller-Klieser, W., Chance, B., and Dewhirst, M. W., 2001, Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. Int J Radiat Oncol Biol Phys, 51:840–848.
Helmlinger, G., Yuan, F., Dellian, M., and Jain, R. K., 1997, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med, 3:177–182.
Schlappack, O. K., Zimmermann, A., and Hill, R. P., 1991, Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer, 64:663–670.
Jang, A., and Hill, R. P., 1997, An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis, 15:469–483.
Kalliomaki, T. and Hill, R. P., 2004, Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines. Br J Cancer, 13:13.
Knocke, T. H., Weitmann, H. D., Feldmann, H. J., Selzer, E., and Potter, R., 1999, Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol, 53:99–104.
Sundfør, K., Lyng, H., Trope, C. G., and Rofstad, E. K., 2000, Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol, 54:101–107.
Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L., and Hill, R. P., 2002, Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol, 20:680–687.
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfor, K., Rofstad, E. K., and Mueller-Klieser, W., 2000, High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res, 60:916–921.
Milosevic, M., Fyles, A., Hedley, D., Pintilie, M., Levin, W., Manchul, L., and Hill, R., 2001, Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res, 61:6400–6405.
Nordsmark, M., Overgaard, M., and Overgaard, J., 1996, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol, 41:31–39.
Brizel, D. M., Dodge, R. K., Clough, R. W., and Dewhirst, M. W., 1999, Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol, 53:113–117.
Adam, M. F., Gabalski, E. C., Bloch, D. A., Oehlert, J. W., Brown, J. M., Elsaid, A. A., Pinto, H. A., and Terris, D. J., 1999, Tissue oxygen distribution in head and neck cancer patients. Head Neck, 21:146–153.
Nordsmark, M. and Overgaard, J., 2000, A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol, 57:39–43.
Rudat, V., Stadler, P., Becker, A., Vanselow, B., Dietz, A., Wannenmacher, M., Molls, M., Dunst, J., and Feldmann, H. J., 2001, Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol, 177:462–468.
Walenta, S., Salameh, A., Lyng, H., Evensen, J. F., Mitze, M., Rofstad, E. K., and Mueller-Klieser, W., 1997, Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol, 150:409–415.
Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., and Mueller-Klieser, W., 2001, Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys, 51:349–353.
Allal, A. S., Dulguerov, P., Allaoua, M., Haenggeli, C. A., El-Ghazi el, A., Lehmann, W., and Slosman, D. O., 2002, Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol, 20:1398–1404.
Nordsmark, M., Alsner, J., Keller, J., Nielsen, O. S., Jensen, O. M., Horsman, M. R., and Overgaard, J., 2001, Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer, 84:1070–1075.
Walenta, S., Chau, T. V., Schroeder, T., Lehr, H. A., Kunz-Schughart, L. A., Fuerst, A., and Mueller-Klieser, W., 2003, Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol, 129:321–326. (Epub 2003, Jun 2025.)
Kunkel, M., Forster, G. J., Reichert, T. E., Kutzner, J., Benz, P., Bartenstein, P., and Wagner, W., 2003, Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol, 39:170–177.
Inoue, T., Yutani, K., Taguchi, T., Tamaki, Y., Shiba, E., and Noguchi, S., 2004, Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography. J Cancer Res Clin Oncol, 24:24.
Vaupel, P., Kallinowski, F., and Okunieff, P., 1989, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res, 49:6449–6465.
Thews, O., Kelleher, D. K., Esser, N., Kraus, S., and Vaupel, P., 2003, Lack of association between tumor hypoxia, GLUT-1 expression and glucose uptake in experimental sarcomas. Adv Exp Med Biol, 510:57–61.
Rajendran, J. G., Mankoff, D. A., O'sullivan, F., Peterson, L. M., Schwartz, D. L., Conrad, E. U., Spence, A. M., Muzi, M., Farwell, D. G., and Krohn, K. A., 2004, Hypoxia and glucose metabolism in malignant tumors: evaluation by [(18)f]fluoromisonidazole and [(18)f]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res, 10:2245–2252.
Milosevic, M., Fyles, A., and Hill, R., 2001, Interstitial fluid pressure in cervical cancer: guide to targeted therapy. Am J Clin Oncol, 24:516–521.
Jain, R. K., 1994, Barriers to drug delivery in solid tumors. Sci Am, 271:58–65.
Nathanson, S. D., and Nelson, L., 1994, Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol, 1:333–338.
Rofstad, E. K., Tunheim, S. H., Mathiesen, B., Graff, B. A., Halsør, E. F., Nilsen, K., and Galappathi, K., 2002, Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res, 62:661–664.
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al., 2002, Lymphatic metastasis in the absence of functional intratumor lymphatics. Science, 296:1883–1886. (Epub 2002 Apr 1825.)
Yuan, J., and Glazer, P. M., 1998, Mutagenesis induced by the tumor microenvironment. Mutat Res, 400:439–446.
Jackson, A. L., and Loeb, L. A., 2001, The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res, 477:7–21.
Marnett, L. J., 2002, Oxy radicals, lipid peroxidation and DNA damage. Toxicology, 181–182:219–222.
Cobbs, C. S., Whisenhunt, T. R., Wesemann, D. R., Harkins, L. E., Van Meir, E. G., and Samanta, M., 2003, Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res, 63:8670–8673.
Turpaev, K. T., 2002, Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc), 67:281–292.
Brown, N. S., and Bicknell, R., 2001, Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res, 3:323–327. (Epub 2001 Jul 2023.)
Yuan, J., Narayanan, L., Rockwell, S., and Glazer, P. M., 2000, Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res, 60:4372–4376.
Mihaylova, V. T., Bindra, R. S., Yuan, J., Campisi, D., Narayanan, L., Jensen, R., Giordano, F., Johnson, R. S., Rockwell, S., and Glazer, P. M., 2003, Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol, 23:3265–3273.
Kondo, A., Safaei, R., Mishima, M., Niedner, H., Lin, X., and Howell, S. B., 2001, Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Res, 61:7603–7607.
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J., 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379:88–91.
Kim, C. Y., Tsai, M. H., Osmanian, C., Graeber, T. G., Lee, J. E., Giffard, R. G., DiPaolo, J. A., Peehl, D. M., and Giaccia, A. J., 1997, Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res, 57:4200–4204.
Williams, A. C., Collard, T. J., and Paraskeva, C., 1999, An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene, 18:3199–3204.
Malins, D. C., Polissar, N. L., and Gunselman, S. J. 1996, Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci U S A 93: 2557–2563.
Guven, M., Ozturk, B., Sayal, A., Ozeturk, A., and Ulutin, T., 1999, Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem Biophys, 17:155–162.
Hockel, M., Schlenger, K., Hockel, S., and Vaupel, P., 1999, Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res, 59:4525–4528.
Nagao, M., Ochiai, M., Okochi, E., Ushijima, T., and Sugimura, T., 2001, LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences. Mutat Res, 477:119–124.
Limoli, C. L., Giedzinski, E., Morgan, W. F., Swarts, S. G., Jones, G. D., and Hyun, W., 2003, Persistent oxidative stress in chromosomally unstable cells. Cancer Res, 63:3107–3111.
Semenza, G. L., 2003, Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3:721–732.
Hopfl, G., Ogunshola, O., and Gassmann, M., 2004, HIFs and tumors—causes and consequences. Am J Physiol Regul Integr Comp Physiol, 286:R608–623.
Koshikawa, N., Iyozumi, A., Gassmann, M., and Takenaga, K., 2003, Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene, 22:6717–6724.
Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R., and Giaccia, A. J., 2003, Investigating hypoxic tumor physiology through gene expression patterns. Oncogene, 22:5907–5914.
Abramovitch, R., Tavor, E., Jacob-Hirsch, J., Zeira, E., Amariglio, N., Pappo, O., Rechavi, G., Galun, E., and Honigman, A., 2004, A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res, 64:1338–1346.
Chambers, A. F., Groom, A. C., and MacDonald, I. C., 2002, Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2:563–572.
Cairns, R. A., Khokha, R., and Hill, R. P., 2003, Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med, 3:659–671.
Liotta, L. A. and Kohn, E. C., 2001, The microenvironment of the tumour—host interface. Nature, 411:375–379.
Postovit, L. M., Adams, M. A., Lash, G. E., Heaton, J. P., and Graham, C. H., 2002, Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem, 277:35730–35737. (Epub 32002 Jul 35739.)
Rofstad, E. K., Rasmussen, H., Galappathi, K., Mathiesen, B., Nilsen, K., and Graff, B. A., 2002, Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res, 62:1847–1853.
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., and Comoglio, P. M., 2003, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3:347–361.
Niizeki, H., Kobayashi, M., Horiuchi, I., Akakura, N., Chen, J., Wang, J., Hamada, J. I., Seth, P., Katoh, H., Watanabe, H., et al., 2002, Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer, 86:1914–1919.
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., and Krek, W., 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature, 425:307–311.
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al., 2003, Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med, 198:1391–1402.
Martinez-Zaguilan, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., and Hendrix, M. J., 1996, Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis, 14:176–186.
Reshkin, S. J., Bellizzi, A., Albarani, V., Guerra, L., Tommasino, M., Paradiso, A., and Casavola, V., 2000, Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J Biol Chem, 275:5361–5369.
Kato, Y., Nakayama, Y., Umeda, M., and Miyazaki, K., 1992, Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem, 267:11424–11430.
Canning, M. T., Postovit, L. M., Clarke, S. H., and Graham, C. H., 2001, Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res, 267:88–94.
Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Koch, C., Evans, S., Ibrahim, H., Le, Q. T., Terris, D. J., et al., 2000, Candidate genes for the hypoxic tumor phenotype. Cancer Res, 60:883–887.
Cuvier, C., Jang, A., and Hill, R. P., 1997, Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin Exp Metastasis, 15:19–25.
Sloane, B. F., Rozhin, J., Krepela, E., Ziegler, G., and Sameni, M., 1991, The malignant phenotype and cysteine proteinases. Biomed Biochim Acta, 50:549–554.
Scandurro, A. B., Weldon, C. W., Figueroa, Y. G., Alam, J., and Beckman, B. S., 2001, Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol, 19:129–135.
Le, Q. T., Sutphin, P. D., Raychaudhuri, S., Yu, S. C., Terris, D. J., Lin, H. S., Lum, B., Pinto, H. A., Koong, A. C., and Giaccia, A. J., 2003, Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res, 9:59–67.
Fukumura, D., Xu, L., Chen, Y., Gohongi, T., Seed, B., and Jain, R. K., 2001, Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res, 61:6020–6024.
Marjon, P. L., Bobrovnikova-Marjon, E. V., and Abcouwer, S. F., 2004, Expression of the proangiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress. Mol Cancer, 3:4.
Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., and Xie, K., 1999, Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res, 5:3711–3721.
Karashima, T., Sweeney, P., Kamat, A., Huang, S., Kim, S. J., Bar-Eli, M., McConkey, D. J., and Dinney, C. P., 2003, Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res, 9:2786–2797.
Hartmann, A., Kunz, M., Kostlin, S., Gillitzer, R., Toksoy, A., Brocker, E. B., and Klein, C. E., 1999, Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res, 59:1578–1583.
Le, Y. J. and Corry, P. M., 1999, Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway. Mol Cell Biochem, 202:1–8.
Griffiths, L., Dachs, G. U., Bicknell, R., Harris, A. L., and Stratford, I. J., 1997, The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res, 57:570–572.
Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., and Muschel, R. J., 2000, Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med, 6:100–102.
Wong, C. W., Song, C., Grimes, M. M., Fu, W., Dewhirst, M. W., Muschel, R. J., and Al-Mehdi, A. B., 2002, Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol, 161:749–753.
Zeelenberg, I. S., Ruuls-Van Stalle, L., and Roos, E., 2003, The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res, 63:3833–3839.
Wong, C. W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., Al-Mehdi, A. B., Bernhard, E. J., and Muschel, R. J., 2001, Apoptosis: an early event in metastatic inefficiency. Cancer Res, 61:333–338.
Harris, A. L., 2002, Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer, 2:38–47.
Dong, Z., Wang, J. Z., Yu, F., and Venkatachalam, M. A., 2003, Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2. Am J Pathol, 163:663–671.
Seimiya, H., Tanji, M., Oh-hara, T., Tomida, A., Naasani, I., and Tsuruo, T., 1999, Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells. Biochem Biophys Res Commun, 260:365–370.
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., and Groom, A. C., 1998, Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol, 153:865–873.
Yoshida, B. A., Sokoloff, M. M., Welch, D. R., and Rinker-Schaeffer, C. W., 2000, Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst, 92:1717–1730.
Egeblad, M. and Werb, Z., 2002, New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2:161–174.
Burbridge, M. F., West, D. C., Atassi, G., and Tucker, G. C., 1999, The effect of extracellular pH on angiogenesis in vitro. Angiogenesis, 3:281–288.
Weidner, N., 1998, Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol, 184:119–122.
Rofstad, E. K. and Halsor, E. F., 2000, Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res, 60:4932–4938.
Poon, R. T., Fan, S. T., and Wong, J., 2001, Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol, 19:1207–1225.
Takanami, I., Takeuchi, K., Naruke, M., Kodaira, S., Tanaka, F., Watanabe, H., and Raz, A., 1998, Autocrine motility factor in pulmonary adenocarcinomas: results of an immunohistochemical study. Tumour Biol, 19:384–389.
Vordermark, D. and Brown, J. M., 2003, Endogenous Markers of Tumor Hypoxia. Predictors of Clinical Radiation Resistance? Strahlenther Onkol, 179:801–811.
Bussink, J., Kaanders, J. H., and van der Kogel, A. J., 2003, Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol, 67:3–15.
Hedley, D., Pintilie, M., Woo, J., Morrison, A., Birle, D., Fyles, A., Milosevic, M., and Hill, R., 2003, Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res, 9:5666–5674.
Bui, M. H., Seligson, D., Han, K. R., Pantuck, A. J., Dorey, F. J., Huang, Y., Horvath, S., Leibovich, B. C., Chopra, S., Liao, S. Y., et al., 2003, Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res, 9:802–811.
Watson, P. H., Chia, S. K., Wykoff, C. C., Han, C., Leek, R. D., Sly, W. S., Gatter, K. C., Ratcliffe, P., and Harris, A. L., 2003, Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer, 88:1065–1070.
Levicar, N., Kos, J., Blejec, A., Golouh, R., Vrhovec, I., Frkovic-Grazio, S., and Lah, T. T., 2002, Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect Prev, 26:42–49.
Kayser, K., Richter, N., Hufnagl, P., Kayser, G., Kos, J., and Werle, B., 2003, Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. Anticancer Res, 23:2767–2772.
Scorilas, A., Fotiou, S., Tsiambas, E., Yotis, J., Kotsiandri, F., Sameni, M., Sloane, B. F., and Talieri, M., 2002, Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem, 383:1297–1303.
Spano, J. P., Andre, F., Morat, L., Sabatier, L., Besse, B., Combadiere, C., Deterre, P., Martin, A., Azorin, J., Valeyre, D., et al., 2004, Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol, 15:613–617.
Yuan, A., Yang, P. C., Yu, C. J., Chen, W. J., Lin, F. Y., Kuo, S. H., and Luh, K. T., 2000, Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med, 162:1957–1963.
Kassim, S. K., El-Salahy, E. M., Fayed, S. T., Helal, S. A., Helal, T., Azzam Eel, D., and Khalifa, A., 2004, Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem, 37:363–369.
Ren, Y., Poon, R. T., Tsui, H. T., Chen, W. H., Li, Z., Lau, C., Yu, W. C., and Fan, S. T., 2003, Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res, 9:5996–6001.
Nurnberg, W., Tobias, D., Otto, F., Henz, B. M., and Schadendorf, D., 1999, Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol, 189:546–551.
Dai, D. L., Makretsov, N., Campos, E. I., Huang, C., Zhou, Y., Huntsman, D., Martinka, M., and Li, G., 2003, Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res, 9:4409–4414.
Hay, R., Cao, B., Tsarfaty, I., Tsarfaty, G., Resau, J., and Woude, G. V., 2002, Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use. J Cell Biochem Suppl, 39:184–193.
Vihinen, P. and Kahari, V. M., 2002, Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer, 99:157–166.
Rittling, S. R., and Chambers, A. F., 2004, Role of osteopontin in tumour progression. Br J Cancer, 90:1877–1881.
Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J., 1997, The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer, 72:1–22.
Schmitt, M., Harbeck, N., Thomssen, C., Wilhelm, O., Magdolen, V., Reuning, U., Ulm, K., Hofler, H., Janicke, F., and Graeff, H., 1997, Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost, 78:285–296.
Jiang, Y., Goldberg, I. D., and Shi, Y. E., 2002, Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene, 21:2245–2252.
Zucker, S., Hymowitz, M., Conner, C., Zarrabi, H. M., Hurewitz, A. N., Matrisian, L., Boyd, D., Nicolson, G., and Montana, S., 1999, Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci, 878:212–227.
de Bock, C. E., and Wang, Y., 2004, Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer. Med Res Rev, 24:13–39.
Rafajova, M., Zatovicova, M., Kettmann, R., Pastorek, J., and Pastorekova, S., 2004, Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol, 24:995–1004.
Creighton, C., Kuick, R., Misek, D. E., Rickman, D. S., Brichory, F. M., Rouillard, J. M., Omenn, G. S., and Hanash, S., 2003, Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Gesnome Biol, 4:R46.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Måseide, K., Kalliomäki, T., Hill, R.P. (2005). Microenvironmental Effects on Tumour Progression and Metastasis. In: Meadows, G.G. (eds) Integration/Interaction of Oncologic Growth. Cancer Growth and Progression, vol 15. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3414-8_1
Download citation
DOI: https://doi.org/10.1007/1-4020-3414-8_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3413-8
Online ISBN: 978-1-4020-3414-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)